Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.

BenzingaApr 23 01:26

MRIN, WISA and SMFL Among Mid-day Movers

Seeking AlphaApr 23 00:52

Inhibikase Therapeutics Files to Sell Common Stock, Warrants

Seeking AlphaApr 20 05:26

Inhibikase Therapeutics Updates Shareholders on Future Plans

TipRanksApr 19 18:13

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

BOSTON and ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to

GlobeNewswireApr 19 04:30

Inhibikase Therapeutics Announces Apr. 5 Pre-IND Meeting With FDA For IkT-001Pro In Pulmonary Arterial Hypertension

Inhibikase Therapeutics Announces Apr. 5 Pre-IND Meeting With FDA For IkT-001Pro In Pulmonary Arterial Hypertension

BenzingaApr 3 20:07